The impact of chromosomal microarray on clinical management: A retrospective analysis

Genetics in Medicine

Volumn 16, Issue 9, 2014, Pages 657-664

  Henderson, Lindsay B ^a   Applegate, Carolyn D ^a   Wohler, Elizabeth ^b   Sheridan, Molly B ^a   Hoover Fong, Julie ^a   Batista, Denise A S ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autism; chromosomal microarray; clinical management; clinical utility; intellectual disability

Indexed keywords

ARTICLE; AUTISM; CANCER SCREENING; CHILD; CHROMOSOMAL MICROARRAY; CYTOGENETICS; DEVELOPMENTAL DISORDER; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIPLE MALFORMATION SYNDROME; PRESCHOOL CHILD; RETROSPECTIVE STUDY; DISEASE MANAGEMENT; DNA MICROARRAY; EARLY DIAGNOSIS; FOLLOW UP; GENETIC SCREENING; HUMAN CHROMOSOME; INFANT; PATIENT REFERRAL; PROCEDURES; SINGLE NUCLEOTIDE POLYMORPHISM;

CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN; DISEASE MANAGEMENT; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GENETIC TESTING; HUMANS; INFANT; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 84908102963     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2014.18     Document Type: Article

References (33)

1. Shevell M, Ashwal S, Donley D, et al.; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003;60:367-380.
2. Ravnan JB, Tepperberg JH, Papenhausen P, et al. Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet 2006;43:478-489.
3. Rauch A, Hoyer J, Guth S, et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am J Med Genet A 2006;140:2063-2074.
4. Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010;12:742-745.
5. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-764.
6. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-846.
7. Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science 2007;316:445-449.
8. Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-488.
9. Cook EH Jr, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008;455:919-923.
10. Stefansson H, Rujescu D, Cichon S, et al.; GROUP. Large recurrent microdeletions associated with schizophrenia. Nature 2008;455:232-236.
11. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009;460:748-752.
12. Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010;6:e1000962.
13. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011;13:777-784.
14. Verhagen JM, Diderich KE, Oudesluijs G, et al. Phenotypic variability of atypical 22q11.2 deletions not including TBX1. Am J Med Genet A 2012;158A:2412-2420.
15. Ellison JW, Ravnan JB, Rosenfeld JA, et al. Clinical utility of chromosomal microarray analysis. Pediatrics 2012;130:e1085-e1095.
16. Department of Health and Human Services. Coverage and Reimbursement of Genetic Tests and Services: Report of the Secretarys Advisory Committee on Genetics, Health, and Society. http://oba.od.nih.gov/oba/sacghs/reports/CR-report.pdf.
17. The Lewin Group. The Value of Diagnostics: Innovation, Adoption and Diffusion into Health Care. http://www.lewin.com/publications/publication/237/. Accessed 25 June 2013.
18. The Lewin Group. The Value of Laboratory Screening and Diagnostic Tests for Prevention and Health Care Improvement. http://www.lewin.com/publications/publication/388/. Accessed 25 June 2013.
19. Riggs E, Wain K, Riethmaier D, et al. Chromosomal microarray impacts clinical management. Clin Genet 2014;85:147-153.
20. Coulter ME, Miller DT, Harris DJ, et al. Chromosomal microarray testing influences medical management. Genet Med 2011;13:770-776.
21. Lee C, Iafrate AJ, Brothman AR. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat Genet 2007;39(suppl 7): S48-S54.
22. Zhang J, Feuk L, Duggan GE, Khaja R, Scherer SW. Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet Genome Res 2006;115:205-214.
23. Shaikh TH, Gai X, Perin JC, et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009;19:1682-1690.
24. Hilhorst-Hofstee Y, Hamel BC, Verheij JB, et al. The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet 2011;19:247-252.
25. Shotelersuk V, Larson D, Anikster Y, et al. CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 1998;63:1352-1362.
26. Gahl WA, Reed GF, Thoene JG, et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 1987;316:971-977.
27. Cohen P, Rogol AD, Deal CL, et al.; 2007 ISS Consensus Workshop participants. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210-4217.
28. Burt RW, Barthel JS, Dunn KB, et al.; NCCN. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010;8:8-61.
29. VHL Family Alliance. The VHL Handbook (fourth edn). http://vhl.org/wordpress/library/Handbook/handbook40.pdf. Accessed 2 October 2013.
30. Baujat G, Rio M, Rossignol S, et al. Paradoxical NSD1 mutations in Beckwith- Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. Am J Hum Genet 2004;74:715-720.
31. Terada Y, Imoto I, Nagai H, et al. An 8-cM interstitial deletion on 4q21-q22 in DNA from an infant with hepatoblastoma overlaps with a commonly deleted region in adult liver cancers. Am J Med Genet 2001;103:176-180.
32. Birsner ML, Hoover-Fong J, Bytyci Telegrafi A, Hueppchen NA. Perinatal detection of familial adenomatous polyposis. Obstet Gynecol 2012;120(2 Pt 2):500-503.
33. McDonald-McGinn D, Emanuel B, Zackai E. 22q11.2 Deletion syndrome. http://www.ncbi.nlm.nih.gov/books/NBK1523/. Accessed 2 October 2013.